دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0190-9622(23)02789-5
Volume 89, Issue 5, November 2023, Pages A4, A6, A8, A17-A18, A21-A22, A24, A34-A35, A39-A40
Information for Readers
doi : 10.1016/S0190-9622(23)02790-1
Volume 89, Issue 5, November 2023, Page A50
JAAD Case Reports Article List
doi : 10.1016/S0190-9622(23)02791-3
Volume 89, Issue 5, November 2023, Pages A51-A53
Journal Based CME Instructions and Information
doi : 10.1016/S0190-9622(23)02792-5
Volume 89, Issue 5, November 2023, Page A54
Gaps in medical education curricula on skin of color in medical school, residency, and beyond: Part 1
Nicole C. Syder, BA, a Deega Omar, BA, MPH, b,c Shanice McKenzie, MD, a Jessica B. Brown-Korsah, BS, b,d Susan C. Taylor, MD, b and Nada Elbuluk, MD, MSc
doi : 10.1016/j.jaad.2022.03.053
Volume 89, Issue 5, November 2023, Pages 885-892
Answers to CME examination
doi : 10.1016/j.jaad.2023.09.034
Volume 89, Issue 5, November 2023, Page 894
Racial and ethnic disparities in clinical research and the dermatology workforce: Part 2
Deega Omar, BA, MPH, a,b Nicole Syder, BS, c Jessica B. Brown-Korsah, BS, b,d Shanice McKenzie, MD, c Nada Elbuluk, MD, MSc, c and Susan Taylor, MD
doi : 10.1016/j.jaad.2022.03.052
Volume 89, Issue 5, November 2023, Pages 895-902
Answers to CME examination
doi : 10.1016/j.jaad.2023.09.036
Volume 89, Issue 5, November 2023, Page 904
Letter from the Editor: Aggressive malignancy in the setting of erosive pustular dermatosis of the scalp
Dirk M. Elston, MD
This month in JAAD: November 2023
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.08.080
Volume 89, Issue 5, November 2023, Page 906
This Month in JAAD Case Reports: November 2023 – High-dose vitamin D and radiation dermatitis
Brett Sloan, MD
doi : 10.1016/j.jaad.2023.08.079
Volume 89, Issue 5, November 2023, Page 907
This Month in JAAD International: November 2023: The total-body skin examination and skin cancer screening
Jonathan Kantor, MD, MSc, MSCE
doi : 10.1016/j.jaad.2023.09.002
Volume 89, Issue 5, November 2023, Page 908
Dermatofibrosarcoma protuberans recurrence: Size matters
Warren R. Heymann, MD
doi : 10.1016/j.jaad.2023.09.001
Volume 89, Issue 5, November 2023, Pages 909-910
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
Cheng Zhou, MD, a Xiumin Yang, MD, b Bin Yang, MD, c Guofu Yan, MD, d Xiuqin Dong, MD, e Yangfeng Ding, MD, f Weixin Fan, MD, g Linfeng Li, MD, h Dingquan Yang, MD, i Hong Fang, MD, j Chao Ji, MD, k Hao Cheng, MD, l Shoumin Zhang, MD, m Aik Han Goh, MD, n Rongjun Liu, MD, n Xiaoyu Gu, MD, n Zaili Weng, MS, n Peter Foley, MBBS, MD, o Rodney Sinclair, MBBS, MD, p and Jianzhong Zhang, MD, PhD
doi : 10.1016/j.jaad.2023.02.063
Volume 89, Issue 5, November 2023, Pages 911-919
Shared decision-making and satisfaction with care in patients with psoriasis: AÂ population-based study in the United States
Danielle Yee, MD, a Paige Kingston, BS, a Kathryn Lee, BA, b Margaret Huang, BS, a Hannah Peterson, BS, c Edwin Korouri, BS, d and April W. Armstrong, MD, MPH
doi : 10.1016/j.jaad.2023.03.039
Volume 89, Issue 5, November 2023, Pages 920-926
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials
Linda Stein Gold, MD, a Edward Lain, MD, b James Q. Del Rosso, DO, c,d,e Michael Gold, MD, f Zoe D. Draelos, MD, g Lawrence F. Eichenfield, MD, h Neil Sadick, MD, i,j William P. Werschler, MD, k Melinda J. Gooderham, MD, l and Mary Lupo, MD m
doi : 10.1016/j.jaad.2022.08.069
Volume 89, Issue 5, November 2023, Pages 927-935
Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial
Jerry Bagel, MD, MS, a Linda Stein Gold, MD, b James Del Rosso, DO, c Sandy Johnson, MD, d Paul Yamauchi, MD, PhD, e Philip M. Brown, MD, JD, f Neal Bhatia, MD, g Angela Yen Moore, MD, h and Anna M. Tallman, PharmD
doi : 10.1016/j.jaad.2023.04.061
Volume 89, Issue 5, November 2023, Pages 936-944
DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial
Lawrence F. Eichenfield, MD, a Janet C. DuBois, MD, b Michael H. Gold, MD, c Christopher J. Nardo, MPH, PhD, d and Zoe D. Draelos, MD, e as part of the DMT310 Study Group
doi : 10.1016/j.jaad.2023.05.070
Volume 89, Issue 5, November 2023, Pages 945-951
OnabotulinumtoxinA improves oral aperture in patients with scleroderma: AÂ small clinical trial
Cristian D. Gonzalez, MD, a Jarod John Pamatmat, MD, b Kevin M. Burningham, MD, b Michelle Yang, MD, a and Heather W. Goff, MD, MPH
doi : 10.1016/j.jaad.2023.04.069
Volume 89, Issue 5, November 2023, Pages 952-958
Histologic margin status is a predictor of relapse in lentigo maligna melanoma
Mai P. Hoang, MD, a Pawel Karpinski, PhD, b,c Miguel Z u~niga-Castillo, MD, PhD, a Ruth K. Foreman, MD, PhD, a Kevin S. Emerick, MD, d and Arthur J. Sober, MD
doi : 10.1016/j.jaad.2023.07.008
Volume 89, Issue 5, November 2023, Pages 959-966
External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database
Steven Caleb Freeman, MD, a Elena Paz Munoz, BS, a Emile Latour, MS, b Jeong Youn Lim, PhD, b and Wesley Yu, MD
doi : 10.1016/j.jaad.2023.07.011
Volume 89, Issue 5, November 2023, Pages 967-973
Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry
Joy Q. Jin, AB, a,b Angel Cronin, MS, c Carla Roberts-Toler, MSc, c Samuel Yeroushalmi, BS, b Edward Hadeler, MD, b Riley K. Spencer, MA, b Kareem G. Elhage, BA, b George Gondo, MA, d Elizabeth B. Wallace, MD, e Soumya M. Reddy, MD, f George Han, MD, PhD, g Jessica Kaffenberger, MD, h Mitchell S. Davis, MD, b Marwa Hakimi, MD, b Jose U. Scher, MD, f April W. Armstrong, MD, MPH, i Tina Bhutani, MD, MAS, b Robert R. McLean, DSc, MPH, c and Wilson Liao, MD
doi : 10.1016/j.jaad.2023.06.058
Volume 89, Issue 5, November 2023, Pages 974-983
Utility of nailfold capillary assessment for predicting pustulotic arthro-osteitis in palmoplantar pustulosis based on a prospective cohort study
Takemichi Fukasawa, MD, PhD, a,b Takashi Yamashita, MD, PhD, a Atsushi Enomoto, PhD, c Satoshi Toyama, MD, PhD, a Asako Yoshizaki-Ogawa, MD, PhD, a Shoko Tateishi, MD, PhD, d Hiroko Kanda, MD, PhD, d Kiyoshi Miyagawa, MD, PhD, c Shinichi Sato, MD, PhD, a and Ayumi Yoshizaki, MD, PhD
doi : 10.1016/j.jaad.2023.07.1014
Volume 89, Issue 5, November 2023, Pages 984-991
Predictors of patient satisfaction with Mohs micrographic surgery at time of surgery and 3 months postsurgery: AÂ prospective cohort study
Katherine G. Thompson, MD, a Divya Manoharan, BA, b Raghav Tripathi, MD, MPH, a Emanuelle Rizk, BA, b Jonathan Lai, BA, b Jenny Carpenter, MHS, b Davies Gage, BS, c Sumrah Jilani, BS, b Shirley Lin, BS, b Kristin P. Bibee, MD, PhD, a,d and Jeffrey F. Scott, MD a
doi : 10.1016/j.jaad.2023.06.046
Volume 89, Issue 5, November 2023, Pages 992-1000
Retrospective analysis shows the cost of Mohs surgery decreases when adjusted for medical inflation
Ashwath J. Sampath, MD, a Karina Paci, MD, MBA, a Osward Y. Carrasquillo, MD, MPH, a Steven Maczuga, BS, b Melissa Butt, DrPH, c,d Bradley Merritt, MD, a Mathew Helm, MD, b and Galen T. Foulke, MD
doi : 10.1016/j.jaad.2023.06.041
Volume 89, Issue 5, November 2023, Pages 1001-1006
Prevalence of allergic contact dermatitis in children with and without atopic dermatitis: A multicenter retrospective case-control study
Hadley Johnson, BS, a,b Marcella R. Aquino, MD, c,d Alan Snyder, MD, MSCR, e Reid W. Collis, MD, f Katlein Franca, MS, MSc, PhD, g Alina Goldenberg, MD, MAS, h,i Jennifer Y. Sui, BA, j,k Dawn Z. Eichenfield, MD, PhD, j,k Brittany J. Kozy, MS, RN, CPNP, l Jennifer K. Chen, MD, m Chelsea Shope, MD MSCR, e Ari M. Goldminz, MD, n and JiaDe Yu, MD, MS
doi : 10.1016/j.jaad.2023.06.048
Volume 89, Issue 5, November 2023, Pages 1007-1014
Characteristics and complications of anogenital infantile hemangiomas: A multicenter retrospective analysis
Justin D. Arnold, MD, MMSc, a,b SunJung Yoon, MS, c Nidhi Shah, MD, b Morgan Byrne, MPH, d Lukas Kieswetter, MD, e Cathryn Sibbald, MD, MSc, e Irene Lara-Corrales, MD, MSc, e Neha Kinariwalla, MD, f Maria C. Garzon, MD, g Mitchell Braun, MD, h Sonal D. Shah, MD, h,i Ilona J. Frieden, MD, h Nicole Travis, BS, j Carmen Liy Wong, MD, j Alan N. Snyder, MD, k Lara Wine Lee, MD, PhD, k Erin K. Collier, MD, l Marcia Hogeling, MD, l Esteban Fernandez Faith, MD, m Nicole DeVaul, PhD, n and Anna Yasmine Kirkorian, MD
doi : 10.1016/j.jaad.2023.06.049
Volume 89, Issue 5, November 2023, Pages 1015-1021
Defining and quantifying histopathologic risk factors for regional and distant metastases in a large cohort of vulvar squamous cell carcinomas
Shayan Cheraghlou, MD, Nicole A. Doudican, PhD, Maressa C. Criscito, MD, Mary L. Stevenson, MD, and John A. Carucci, MD, PhD
doi : 10.1016/j.jaad.2023.03.049
Volume 89, Issue 5, November 2023, Pages 1022-1030
Relatlimab–nivolumab: A practical overview for dermatologists
Nikita Mullick, BS, and Vinod E. Nambudiri, MD, MBA, EdM
doi : 10.1016/j.jaad.2023.06.024
Volume 89, Issue 5, November 2023, Pages 1031-1037
Incidence and time to development of malignancies arising on the scalp of patients with erosive pustular dermatosis based on sex: A retrospective analysis
Norhan Shamloul, MD, MS, a Payvand Kamrani, DO, a Gelan Shamloul, BS, b Allen Kunselman, MA, c Diane Thiboutot, MD, a Elizabeth Billingsley, MD, a and Charlene Lam, MD, MPH
doi : 10.1016/j.jaad.2023.05.087
Volume 89, Issue 5, November 2023, Pages 1038-1039
Significant discordance in DermTech test results when paired with histopathology: Caveat emptor
Jonathan Bass, MD, a,b Hannah Hill, MS, c and Christine Jaworsky, MD
doi : 10.1016/j.jaad.2023.07.1022
Volume 89, Issue 5, November 2023, Pages 1039-1041
A multimodal initiative improves general pediatric provider management of atopic dermatitis in children: A prospective interventional study
Stephanie S. Lee, MD, a,b Anshika Kaushik, MD, c Nicola Natsis, MD, a,b Ayan Kusari, MD, d DavidSchairer, MD, a,b Sarah Lindback, MD, b Mark Levenberg, DO, e J. Rebecca Mills, DrPH, e Kathleen Peeples, PharmD, e Richard Smith, PharmD, e and Lawrence F. Eichenfield, MD
doi : 10.1016/j.jaad.2023.02.065
Volume 89, Issue 5, November 2023, Pages 1041-1044
Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience
Abdulhadi Jfri, MD, MSc, a,b Cesar A. Virgen, MD, PhD, a,b,c Marianne Tawa, RN, MSN, ANP, c Anita Giobbie-Hurder, MS, d Thomas S. Kupper, MD, a,b,c David C. Fisher, MD, e Nicole R. LeBoeuf, MD, MPH, a,b,c and Cecilia Larocca, MD
doi : 10.1016/j.jaad.2023.05.082
Volume 89, Issue 5, November 2023, Pages 1044-1047
The anatomic region impacts the duration of action of ropivacaine during dermatologic surgery
Jacob L. Thomas, MD, a,b Kristina Navrazhina, MD, PhD, a,b Kalee Shah, MD, c Tzippy Shochat, MSc, d and Kira Minkis, MD, PhD a,b
doi : 10.1016/j.jaad.2023.06.036
Volume 89, Issue 5, November 2023, Pages 1047-1048
Is the combination of cryotherapy and topical timolol solution superior to cryotherapy alone in the treatment of epidermal growth factor receptor inhibitor-induced paronychia? A double-blinded, left-to-right comparison, randomized controlled trial
Ya-Wen Hsiao, MD, a and Yu-Chen Huang, MD
doi : 10.1016/j.jaad.2023.06.040
Volume 89, Issue 5, November 2023, Pages 1049-1050
Treatment response and tolerability of intralesional quadrivalent versus bivalent human papillomavirus vaccine for recalcitrant warts: A randomized controlled trial
Ahmad Nofal, MD, a Hagar Nofal, MD, a,b Esam Alwirshiffani, MSc, a,c and Mohamed I. ElGhareeb, MD
doi : 10.1016/j.jaad.2023.06.042
Volume 89, Issue 5, November 2023, Pages 1051-1052
Minority enrollment in melanoma clinical trials
Elena Paz Munoz, BS, a Sapna P. Patel, MD, b Sancy A. Leachman, MD, PhD, c,d Nathan Y. Yu, MD, e and Wesley Y. Yu, MD
doi : 10.1016/j.jaad.2023.06.043
Volume 89, Issue 5, November 2023, Pages 1052-1054
Tumor size is the most significant risk factor for local recurrence in dermatofibrosarcoma protuberans: A large-scale retrospective cohort analysis
Imran T. Baig, MD, a Kyle Lauck, MD, b and Quoc- Bao D. Nguyen, MD, MBA
doi : 10.1016/j.jaad.2023.06.044
Volume 89, Issue 5, November 2023, Pages 1054-1056
Prevalence and comorbidity burden of prurigo nodularis in United States adults enrolled in the All of Us research program
Marina Z. Joel, BS, Jourdan Hydol-Smith, BA, Anusha Kambala, BS, Hannah L. Cornman, BS, and Shawn G. Kwatra, MD
doi : 10.1016/j.jaad.2023.06.045
Volume 89, Issue 5, November 2023, Pages 1056-1058
Automatic release of dermatology test results is associated with increased negative emotions and decreased trust in a retrospective analysis of 505 electronic patient portal messages
Julianne M. Falotico, MD, a Asghar Shah, b Amar D. Desai, MPH, c Kaya L. Curtis, BA, d and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2023.06.047
Volume 89, Issue 5, November 2023, Pages 1058-1060
Primary Merkel cell carcinoma is associated with increased, extended risk of subsequent melanoma and nonepithelial skin cancer
Nelson Ugwu, MD, a Shayan Cheraghlou, MD, b and Jonathan Weiss, MD
doi : 10.1016/j.jaad.2023.07.007
Volume 89, Issue 5, November 2023, Pages 1060-1061
Holiday holidays: A reduction in topical medication adherence during the winter holidays
Christina Kontzias, BA, a Heli Patel, BS, a Stuti Prajapati, MS, a Rithi Chandy, MS, a Vani Mangalam Subramanian, BE, b Deepak Sirdeshmukh, PhD, b and Steven R. Feldman, MD, PhD
doi : 10.1016/j.jaad.2023.06.050
Volume 89, Issue 5, November 2023, Pages 1061-1063
Isotretinoin for the management of moderate-to-severe seborrheic dermatitis: A systematic review
Aliyah King, BA, a Marcus G. Tan, MD, a,b Carly Kirshen, MD, a,b and Stanislav N. Tolkachjov, MD
doi : 10.1016/j.jaad.2023.07.010
Volume 89, Issue 5, November 2023, Pages 1063-1066
Adverse cutaneous reactions associated with MEK inhibitor therapy in a pediatric population
Fahad Ahmed, BA, a,b Michael J. Fisher, MD, b,c Kristen M. Snyder, MD, b,c Katherine Smith, MPH, BSN, RN, c Benjamin L. Laskin, MD, MS, b,d and Marissa J. Perman, MD
doi : 10.1016/j.jaad.2023.06.052
Volume 89, Issue 5, November 2023, Pages 1066-1068
Skin of color repigmentation after phenol-croton oil chemical peel
Marcelo L. Paiva, MPP, a Aline S. Justo, PharmD, MSc, b Bruna M. Lemes, PharmD, MSc,b Anna Claudia M. O. Capote, PharmD,b Mayra Buainain de Castro Maymone, DDS, MD, DSc, a Leandro C. Lipinski, VetD, PhD, c Peter P. Rullan, MD, d Fl avio Lu ?s Beltrame, PharmD, PhD, b Helio A. Miot, MD, PhD, e and Carlos G. Wambier, MD, PhD
doi : 10.1016/j.jaad.2023.06.053
Volume 89, Issue 5, November 2023, Pages 1068-1070
Acquired, bilateral nevus of Ota-like macules in children: Clinical findings in 46 patients
Hongjin Wu, MD, a,b Min Li, MD, PhD, a Shen Wang, MD, a Wen Qian, MD, a and Dan Luo, MD, PhD
doi : 10.1016/j.jaad.2023.06.054
Volume 89, Issue 5, November 2023, Pages 1070-1071
EGFR expression is associated with relapse in a melanoma cohort receiving adjuvant PD-1-based immunotherapy
Teresa Amaral, MD, PhD, a,b Oltin Tiberiu Pop, MD, PhD, c Eftychia Chatziioannou, MD, a Tobias Sinnberg, Dr rer nat, a,b,d Heike Niessner, Dr rer nat, a,b Jing Zhao, MSc, e Sandra Stephanie Ring, PhD, f Markus Joerger, MD, PhD, g Christopher Schroeder, MD, h Sorin Armeanu-Ebinger, Dr rer nat, h Antonio Cozzio, MD, Dr sc nat, i Ulrike Leiter, MD, a Ioannis Thomas, MD, a Wolfram Jochum, MD, j Claus Garbe, MD, a Stephan Forchhammer, MD, a Mitchell Levesque, PhD, k Joanna Mangana, MD, k Michael H€olzel, MD, PhD, l Reinhard Dummer, MD, k Christian M. Sch€urch, MD, PhD, e Andrea Forschner, MD, a and Lukas Flatz, MD a
doi : 10.1016/j.jaad.2023.06.057
Volume 89, Issue 5, November 2023, Pages 1072-1074
Serum levels of S-100 protein are directly proportional to the size, number, thickness and degree of cellularity of congenital melanocytic nevi
Alejandra Tom as-Vel azquez, MD, a Juan Carlos L opez-Guti errez, MD, PhD, b Miguel Reyes- M ugica, MD, c Claudia M. Salgado, MD, PhD, c Sandra Herv as-Stubbs, PhD, d Carlos de Andrea, MD, PhD, e Dipanjan Basu, PhD, c Eva M. Andr es, PhD, f Paloma Triana, MD, b Carmen Ceballos, MD, PhD, g Gabriel Reina, PhD, h and Pedro Redondo, MD, PhD a
doi : 10.1016/j.jaad.2023.06.059
Volume 89, Issue 5, November 2023, Pages 1074-1077
Time spent outdoors and sun protective behaviors among sexual minority women
doi : 10.1016/j.jaad.2023.07.1010
Volume 89, Issue 5, November 2023, Pages 1077-1080
Association of histopathologic grade with stage and survival in sebaceous carcinoma: A retrospective cohort study in the National Cancer Database
Nolan J. Maloney, MD, a,b Natasha C. Zacher, MD, a,b Sumaira Z. Aasi, MD, a Kelsey E. Hirotsu, MD, a Lisa C. Zaba, MD, PhD, a,b and Nour Kibbi, MD
doi : 10.1016/j.jaad.2023.07.1013
Volume 89, Issue 5, November 2023, Pages 1080-1083
A prospective cohort study evaluating m6A RNA methylation in cutaneous squamous cell carcinoma
Jake Lazaroff, MD, a Grace Y. Duan, BA, b Michelle Verghese, BA, b Breanna Bertacchi, BA, a Seungwon Yang, PhD, a Yu-Ying He, PhD, a and Diana Bolotin, MD, PhD
doi : 10.1016/j.jaad.2023.07.1017
Volume 89, Issue 5, November 2023, Pages 1083-1084
Re-examining melanoma secondary prevention and the role of skin self-examination
Jenne P. Ingrassia, BA, a,b Prince Adotama, MD, a Jennifer A. Stein, MD, PhD, a and David Polsky, MD, PhD
doi : 10.1016/j.jaad.2023.05.098
Volume 89, Issue 5, November 2023, Pages 1085-1086
COVID-19 booster exemption for severe dyshidrotic eczema
Kathryn Bentivegna, MPH, a Marti J. Rothe, MD, b and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2022.06.1176
Volume 89, Issue 5, November 2023, Pages 1087-1088
Using ultraviolet light in diagnosing scabies: Scabies' Sign via Wood's Lamp
Aslan Y€urekli, MD, a _Ilkay Can, MD, b and Metin O guz, MD
doi : 10.1016/j.jaad.2023.07.006
Volume 89, Issue 5, November 2023, Pages e195-e196
Remedy for split nail using silk wraps and gel resin
Jonathan K. Hwang, BS, Kelita A. Waterton, BS, and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2023.05.005
Volume 89, Issue 5, November 2023, Pages e197-e198
Modification of clip-on earring as pressure earring
Bernard M. H. Liang, BDS, Meng
doi : 10.1016/j.jaad.2021.08.014
Volume 89, Issue 5, November 2023, Pages e199-e200
Ring hemostasis: Preserving the view
Jack Lee, MD, and Mark A. Russell, MD
doi : 10.1016/j.jaad.2021.08.032
Volume 89, Issue 5, November 2023, Pages e201-e202
Application of forceps in nail and toenail surgery
Weilin Cai, MD, a,b Chenyang Wu, MD, a Jianzhong Peng, MD, a and Minliang Chen, MD
doi : 10.1016/j.jaad.2021.10.017
Volume 89, Issue 5, November 2023, Pages e203-e204
Autoclavable metallic skin peeler: Novel modality for paring of callosities
Sheetanshu Kumar, MD, Priya Kapoor, MD, Arwinder Kaur Brar, MD, Shivani Bansal, MD, DNB, and Mohit Kumar Meena, BSc
doi : 10.1016/j.jaad.2021.10.039
Volume 89, Issue 5, November 2023, Pages e205-e206
A modification to the slip “granny� knot for high-tension wound closures
Jose A. Cervantes, MD, a Ikue Shimizu, MD, a Jeremy S. Bordeaux, MD, MPH, b and Ida F. Orengo, MD
doi : 10.1016/j.jaad.2021.10.055
Volume 89, Issue 5, November 2023, Pages e207-e208
Modified distal digital block for nail unit surgery
Neha N. Jariwala, MD, Diego Ruiz Dasilva, MD, Joseph F. Sobanko, MD, and Adam I. Rubin, MD
doi : 10.1016/j.jaad.2021.10.056
Volume 89, Issue 5, November 2023, Pages e209-e210
Optimizing clinical and dermatopathology images with the iPhone operating system (IOS) 16 background removal feature
Travis S. Dowdle, BS, a,b and Michelle B. Tarbox, MD
doi : 10.1016/j.jaad.2022.11.049
Volume 89, Issue 5, November 2023, Pages e211-e212
Interpreting with caution of the lack of association between isotretinoin, depression, and suicide
Chee Hoou Loh, MBBS, MRCP, a,b Yiong Huak Chan, PhD, c and Ellie Choi, MBBS, MRCP
doi : 10.1016/j.jaad.2022.12.054
Volume 89, Issue 5, November 2023, Pages e213-e214
Response to comment on the article entitled “Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study�
Mindy Kresch-Vatch, BS, a,b and Mark Lebwohl, MD
doi : 10.1016/j.jaad.2023.02.006
Volume 89, Issue 5, November 2023, Page e215
Reply to: “Interpreting with caution the lack of association between isotretinoin, depression, and suicide�
Khalaf Kridin, MD, PhD, a,b,c and Ralf J. Ludwig, MD
doi : 10.1016/j.jaad.2023.01.038
Volume 89, Issue 5, November 2023, Page e217
The limits of claims databases: A response to “A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid�
Joshua Hackney, MD, a Robert A. Swerlick, MD, b and James Muir, MBBS
doi : 10.1016/j.jaad.2022.12.055
Volume 89, Issue 5, November 2023, Pages e219-e220
The impact of the COVID-19 pandemic on new diagnoses of melanoma: A response to additional multi-institution and international reports
Adrienne B. Shannon, MD, a and Giorgos C. Karakousis, MD
doi : 10.1016/j.jaad.2023.03.060
Volume 89, Issue 5, November 2023, Pages e221-e222
Response to Trepanowski et al’s “Delays in melanoma presentation during the COVID-19 pandemic: a nationwide multi-institutional cohort study�
Claire Drumm, MD, a Ciara Griffin, MD, b Susan Van Baarsel, MD, c Claire Quigley, MD, c Stephen Madden, PhD, d Jarushka Naidoo, MD, e and Karen Eustace, MD
doi : 10.1016/j.jaad.2023.02.066
Volume 89, Issue 5, November 2023, Pages e223-e224
The impact of the American Academy of Dermatology/International League of Dermatological Societies COVID-19 Registry during the pandemic: 2500 cases across 72 countries
Alexis G. Strahan, MSN, a,b Janet E. Lubov, BSN, a,c Sonya Prasad, MSc, a,d Lindy P. Fox, MD, e Devon E. McMahon, MD, f Rhea Singh, BS, a,g Misha Rosenbach, MD, f,h Seemal R. Desai, MD, i,j Henry W. Lim, MD, k Bruce H. Thiers, MD, l George J. Hruza, MD, MBA, m Lars E. French, MD, n,o and Esther E. Freeman, MD, PhD
doi : 10.1016/j.jaad.2023.04.037
Volume 89, Issue 5, November 2023, Pages e225-e227
Response to Foulad et al’s “Educational and scholarly opportunities for medical students and residents in the United States dermatology societies�
Carrie Diamond, BA, a Michael Seth Flynn, BS, a Khushnood Faraz, BS, a Jennifer Jacobs, BS, a Chandler W. Rundle, MD, b and Christopher Stamey, MD
doi : 10.1016/j.jaad.2023.03.061
Volume 89, Issue 5, November 2023, Pages e229-e233
Comment on “Isotretinoin and the risk of psychiatric disturbances: A global study shedding new light on a debatable story�
Congcong Liu, MM, a,b Weijie Gu, MD, b and Jiayi Xiang, MM
doi : 10.1016/j.jaad.2023.03.063
Volume 89, Issue 5, November 2023, Page e235
Association of atopic dermatitis with substance use disorders: A case-control study in the All of Us research program
Tejas P. Joshi, BS, a Ashley Bancroft, BS, a Danielle DeLeon, MS, b Danielle Garcia, BS, a Bhavana Kunisetty, BS, a Paulina Truong, BS, a and Soo Jung Kim, MD, PhD
doi : 10.1016/j.jaad.2023.06.051
Volume 89, Issue 5, November 2023, Pages e237-e238
Reply to “Atopic comorbidities associated with granuloma annulare: A case-control study of the All of Us database�
Ashley Bancroft, BS, a and Rohit Gupta, MD
doi : 10.1016/j.jaad.2023.06.056
Volume 89, Issue 5, November 2023, Page e239
Heterogenous cytokine profiles in patients with granuloma annulare may indicate immune dysregulation spanning multiple T-cell axes
Tejas P. Joshi, BS, a and Madeleine Duvic, MD
doi : 10.1016/j.jaad.2023.07.1007
Volume 89, Issue 5, November 2023, Pages e241-e242
Reply to ‘Response to the article by Perandones-González H et al entitled “Ex vivo dermoscopy in demodicosis�’
H ector Perandones-Gonz alez, MD, a and Pablo Boixeda, MD, PhD
doi : 10.1016/j.jaad.2023.07.1008
Volume 89, Issue 5, November 2023, Page e243
Response to the article by González HP et al entitled “Ex vivo dermoscopy in demodicosis�
Aslan Y€urekli, MD
doi : 10.1016/j.jaad.2023.06.060
Volume 89, Issue 5, November 2023, Pages e245-e246
Response to Magnaterra et al’s unveiling hydrochlorothiazide: Skin cancer risk and hidden interactions
Laurent Azoulay, PhD, a,b,c Audray St-Jean, MSc, c and Robert W. Platt, PhD
doi : 10.1016/j.jaad.2023.07.1012
Volume 89, Issue 5, November 2023, Pages e247-e248
Unveiling hydrochlorothiazide: Skin cancer risk and hidden interactions
Elisabetta Magnaterra, MD, a Martina Lambertini, MD, b,c Federica Scarf ?, MD, d Massimo Gola, MD, a Emi Dika, PhD, b,c and Vincenzo De Giorgi, MD
doi : 10.1016/j.jaad.2023.06.061
Volume 89, Issue 5, November 2023, Pages e249-e250
Reply to comment on: “Isotretinoin and the risk of psychiatric disturbances - A global study shedding new light on a debatable story�
Khalaf Kridin, MD, PhD, a,b,c and Ralf J. Ludwig, MD
doi : 10.1016/j.jaad.2023.04.049
Volume 89, Issue 5, November 2023, Pages e251-e252
November 2023 iotaderma (#357)
Robert I. Rudolph, MD, FACP
doi : 10.1016/j.jaad.2023.05.002
Volume 89, Issue 5, November 2023, Page e253
